Results of the HIV indicator diseases across Europe survey 2.
| Tested, n | HIV positive, n | Prevalence, % | 95% confidence interval | |
|---|---|---|---|---|
| Lymphoma | 588 | 4 | 0.7 | 0.6–1.3 |
| CIN2/3/cervical cancer | 1,339 | 13 | 1.0 | 0.5–1.5 |
| Anal dysplasia or cancer | 53 | 0 | 0 | n/a |
| Hepatitis B | 1,126 | 13 | 1.2 | 0.5–1.8 |
| Hepatitis C | 1,751 | 41 | 2.3 | 1.6–3.1 |
| Hepatitis B and C | 73 | 7 | 9.6 | 2.8–16.3 |
| Mononucleosis-like illness | 734 | 39 | 5.3 | 3.7–6.9 |
| Leucocytopenia/thromobocytopenia | 401 | 16 | 4.0 | 2.1–5.9 |
| Seborrhoeic dermatitis | 299 | 6 | 2.0 | 0.4–3.6 |
| Pneumonia | 1,881 | 61 | 3.2 | 2.4–4.0 |
| Lymphadenopathy | 722 | 32 | 4.4 | 2.9–5.9 |
| Peripheral neuropathy | 84 | 2 | 2.4 | 0.0–5.1 |
| Lung cancer | 144 | 0 | 0 | n/a |
| Severe psoriasis | 276 | 1 | 0.4 | 0.0–1.1 |
| TOTAL | 9,471 | 235 | 2.5 | 2.2–2.8 |